Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Michal Sieniawski.

Newcastle AuthorsTitleYearFull text
Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study (Bone Marrow Transplantation, (2019), 54, 3, (465-468), 10.1038/s41409-018-0294-2)2020
Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study2019
Dr Michal Sieniawski
Dr Anne Lennard
A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma2015
Dr Rachel Crossland
Dr Tryfonia Mainou-Fowler
Dr Michal Sieniawski
Dr Christopher Bacon
Dr Vikki Rand
et al.
High BACH2 gene Expression Is an Indicator of Poor Prognosis in Adult Diffuse Large B-Cell Lymphoma Treated with R-CHOP2014
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients2014
Dr Rachel Crossland
Dr Michal Sieniawski
Parimala Saminathan
Dr Tryfonia Mainou-Fowler
MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies2013
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Paul Milne
et al.
Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients2013
Dr Michal Sieniawski
Dr Anne Lennard
Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Clinical Features, and Current Treatment Strategies2011
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Dr Susan Proctor
Kate McCabe
et al.
Mature microRNAs of the miR-17-92 cluster predict for disease outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with CHOP-R immunochemotherapy2011
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation2010
Dr Michal Sieniawski
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: A report from the German Hodgkin Study Group (GHSG)2010
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al.
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control2010
Dr Michal Sieniawski
Dr Malcolm Farrow
Elaine Zhao
Dr Jennifer Wilkinson
Dr Tryfonia Mainou-Fowler
et al.
A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction Of Outcome2009
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens2009
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Michal Sieniawski
Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future2009
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Professor Stephen Proctor
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone -Rituximab refractory patients2009
Dr Michal Sieniawski
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology2009
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Dr Anne Lennard
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.
Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.2008
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Sequential Evaluation of Outcome in Enteropathy Associated T Cell Lymphoma Comparing Standard Therapeutic Approaches - Surgery or CHOP-Like Chemotherapy with a New High Dose Ifosfamide/Methotrexate and Autologous Stem Cell Transplant Regimen: A Prospective Study of Scotland and Newcastle Lymphoma Group2008
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Tryfonia Mainou-Fowler
Dr Michal Sieniawski
Dr Katrina Wood
et al.
SHIELD - Study of Hodgkin lymphoma in the elderly/lymphoma data base: Progress report2008
Dr Michal Sieniawski
Dr Tryfonia Mainou-Fowler
Dr Jennifer Wilkinson
Dr John Davison
Professor Graham Jackson
et al.
The effect of Diffuse Large B-Cell Lymphoma (DLBCL) treatment regimens on survival: a prospective cohort study [Poster]2008